LEONARD GOMELLA

Title	Professor & Chair JMC
Institution	Thomas Jefferson University
Department	Chair SKMC
Address	1025 Walnut St. Philadelphia PA 19107
Phone	215-955-1000
vCard	Download vCard

Bibliographic

selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Hochberg AR, Gomella PT, Im B, Ghosh A, Shah S, Thompson RAM, Zarrabi KK, Shah MS, Mark JR, Izes JK, Lallas CD, Gomella LG, Metwalli AR. Is the TriNetX Database a Good Tool for Investigation of Real-World Management of Von Hippel-Lindau? J Kidney Cancer VHL. 2024; 11(4):28-38. PMID: 39678829.

Citations:
Gomella LG. My Morning Commute and the Impact of Urology. Can J Urol. 2024 Dec; 31(6):12030-12031. PMID: 39675033.

Citations:
Bryce AH, Agarwal N, Beltran H, Hussain MH, Sartor O, Shore N, Antonarakis ES, Armstrong AJ, Calais J, Carducci MA, Dorff TB, Efstathiou JA, Gleave M, Gomella LG, Higano C, Hope TA, Iagaru A, Morgans AK, Morris DS, Morris MJ, Petrylak DP, Reiter RE, Rettig MB, Ryan CJ, Sellinger SB, Spratt DE, Srinivas S, Tagawa ST, Taplin ME, Yu EY, Zhang T, McKay RR, Koo PJ, Crawford ED. Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024. Cancer. 2024 Dec 01. PMID: 39616467.

Citations:
Ghoreifi A, Gomella L, Hu JC, Konety B, Lunelli L, Rastinehad AR, Salomon G, Taneja S, Tourinho-Barbosa R, Lebastchi AH. Identifying the best candidate for focal therapy: a comprehensive review. Prostate Cancer Prostatic Dis. 2024 Oct 23. PMID: 39443815.

Citations:
Buraschi S, Xu SQ, Stefanello M, Moskalev I, Morcavallo A, Genua M, Tanimoto R, Birbe R, Peiper SC, Gomella LG, Belfiore A, Black PC, Iozzo RV, Morrione A. Correction: Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatin. Oncotarget. 2024 10 01; 15:697-698. PMID: 39352802.

Citations:
Leader AE, Rebbeck TR, Oh WK, Patel AV, Winer EP, Bailey LO, Gomella LG, Lumpkins CY, Garraway IP, Aiello LB, Baskin ML, Cheng HH, Cooney KA, Ganzak A, George DJ, Halabi S, Hathaway F, Healy C, Kim JW, Leapman MS, Loeb S, Maxwell KN, McNair C, Morgan TM, Prindeville B, Soule HR, Steward WL, Suttiratana SC, Taplin ME, Yamoah K, Fortune T, Bennett K, Blanding-Godbolt J, Gross L, Giri VN. Adaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testing. BMC Public Health. 2024 Sep 18; 24(1):2533. PMID: 39289635.

Citations:
Gomella LG. The Centennial Celebration of the CJU Legends in Urology. Can J Urol. 2024 Aug; 31(4):11915. PMID: 39217513.

Citations:
Sartor O, Karrison TG, Sandler HM, Gomella LG, Amin M, Purdy J, Michalski JM, Garzotto MG, Pervez N, Balogh AG, Rodrigues GB, Souhami L, Neil Reaume M, Williams SG, Hannan R, Jones CU, Horwitz EM, Rodgers JP, Feng FY, Rosenthal SA. Corrigendum to "Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostat Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial" [Eur. Eurol. 84(2) (2023) 156-163]. Eur Urol. 2024 Jun 18. PMID: 38897867.

Citations:
Ghagane SC, Rangrez S, Nerli RB, Thakur ML, Gomella LG. Use of TP4303 to identify prostate cancer cells in voided urine samples. Can J Urol. 2024 Jun; 31(3):11892-11896. PMID: 38912942.

Citations:
Gomella LG. The digital rectal prostate exam: from useful to useless to controversial. Can J Urol. 2024 Jun; 31(3):11864-11866. PMID: 38912935.

Citations:
Narayan VM, Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Mashni J, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Inman BA, Williams MB, Cookson MS, Chang SS, Sankin AI, O'Donnell MA, Sawutz D, Philipson R, Parker NR, Yla-Herttuala S, Rehm D, Jakobsen JS, Juul K, Dinney CPN. Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Gu?rin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial. J Urol. 2024 Jul; 212(1):74-86. PMID: 38704840.

Citations:
Thakur M, Tomar VS, Dale E, Gomella LG, Solomides C, Kolesnikov O, Keith SW, Navarro HT, Dahlgren O, Chaga M, Trabulsi EJ. Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia. BJUI Compass. 2024 Jul; 5(7):675-680. PMID: 39022663.

Citations:
Gomella LG. Is PSMA PET disrupting traditional prostate cancer staging and treatment? Can J Urol. 2024 Apr; 31(2):11814-11815. PMID: 38642457.

Citations:
McPartland C, Salib A, Banks J, Mark JR, Lallas CD, Trabulsi EJ, Gomella LG, Goldberg H, Leiby B, Den R, Chandrasekar T. Risk of Secondary Malignancies After Pelvic Radiation: A Population-based Analysis. Eur Urol Open Sci. 2024 May; 63:52-61. PMID: 38558762.

Citations:
Loeb S, Keith SW, Cheng HH, Leader AE, Gross L, Sanchez Nolasco T, Byrne N, Hartman R, Brown LH, Pieczonka CM, Gomella LG, Kelly WK, Lallas CD, Handley N, Mille PJ, Mark JR, Brown GA, Chopra S, McClellan A, Wise DR, Hollifield L, Giri VN. TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing. JCO Precis Oncol. 2024 Mar; 8:e2300552. PMID: 38452310.

Citations:
Ross AE, Zhang J, Huang HC, Yamashita R, Keim-Malpass J, Simko JP, DeVries S, Morgan TM, Souhami L, Dobelbower MC, McGinnis LS, Jones CU, Dess RT, Zeitzer KL, Choi K, Hartford AC, Michalski JM, Raben A, Gomella LG, Sartor AO, Rosenthal SA, Sandler HM, Spratt DE, Pugh SL, Mohamad O, Esteva A, Chen E, Schaeffer EM, Tran PT, Feng FY. External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial. Eur Urol Oncol. 2024 Jan 31. PMID: 38302323.

Citations:
Gomella LG. The Left Shift in Drugs for Advanced Prostate Cancer. Can J Urol. 2023 Dec; 30(6):11708-11709. PMID: 38104326.

Citations:
Gomella LG. Re: Venture capital investment in urology, 2011 to mid-2021. Can J Urol. 2023 Oct; 30(5):11667. PMID: 37838993.

Citations:
Gomella LG. Prostate cancer screening algorithms and the Affordable Care Act updates. Can J Urol. 2023 Oct; 30(5):11644. PMID: 37838989.

Citations:
Schostak M, Bradbury A, Briganti A, Gonzalez D, Gomella L, Mateo J, Penault-Llorca F, Stenzinger A, Wyatt AW, Bjartell A. Practical Guidance on Establishing a Molecular Testing Pathway for Alterations in Homologous Recombination Repair Genes in Clinical Practice for Patients with Metastatic Prostate Cancer. Eur Urol Oncol. 2023 Sep 13. PMID: 37714762.

Citations:
Gomella LG. The Bladder and the Bowel: More Than Just Neighbors. Can J Urol. 2023 08; 30(4):11583. PMID: 37633283.

Citations:
Gomella LG. Medications That Scare Me: Urology's Turn. Can J Urol. 2023 06; 30(3):11520-11521. PMID: 37344460.

Citations:
Mark JR, Gomella LG, Lallas CD, Smentkowski KE, Calvaresi A, Handley N, Den RB, Mille P, Tester WJ, Hoffman-Censits J, Dicker AP, Klonicke E, Halpern E, McCue P, Kelly WK, Trabulsi EJ. Enhancing bladder cancer care through the multidisciplinary clinic approach. Can J Urol. 2023 06; 30(3):11526-11531. PMID: 37344462.

Citations:
Sartor O, Karrison TG, Sandler HM, Gomella LG, Amin M, Purdy J, Michalski JM, Garzotto MG, Pervez N, Balogh AG, Rodrigues GB, Souhami L, Reaume MN, Williams SG, Hannan R, Jones CU, Horwitz EM, Rodgers JP, Feng FY, Rosenthal SA. Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostate Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial. Eur Urol. 2023 May 11. PMID: 37179241.

Citations:
Gomella LG. Cardio-Oncology, Nephro-Oncology and the Urologic Oncology Collaboration. Can J Urol. 2023 04; 30(2):11457-11458. PMID: 37074741.

Citations:
Shah YB, McPartland C, Wang KR, Simhal RK, Murphy A, Shenot P, Gomella L, Lallas CD. Early Urology Exposure Increases Success in the Residency Match: An Institutional Experience. Urology. 2022 Dec 23. PMID: 36566786.

Citations:
Gomella LG. RVU-itis: Is There A Cure? Can J Urol. 2022 12; 29(6):11340-11341. PMID: 36495572.

Citations:
Foss H, Ragam R, Kelly WK, Gomella LG. Neuroendocrine transformation of prostate adenocarcinoma with corpora cavernosa metastases. Can J Urol. 2022 12; 29(6):11399-11401. PMID: 36495584.

Citations:
Herzog TJ, Vergote I, Gomella LG, Milenkova T, French T, Tonikian R, Poehlein C, Hussain M. Testing for homologous recombination repair or homologous recombination deficiency for poly (ADP-ribose) polymerase inhibitors: A current perspective. Eur J Cancer. 2023 Jan; 179:136-146. PMID: 36563604.

Citations:
Chandrasekar T, Clark CB, Gomella A, Wessner CE, Wang S, Nam K, Liu JB, Forsberg F, Lyshchik A, Halpern E, Mark JR, Lallas CD, Gomella LG, Kania L, Trabulsi EJ, Eisenbrey JR. Volumetric Quantitative Contrast-enhanced Ultrasonography Evaluation of Complex Renal Cysts: An Adjunctive Metric to the Bosniak Classification System to Predict Malignancy. Eur Urol Focus. 2022 Oct 29. PMID: 36319560.

Citations:
D'Amico MJ, Foss H, Uhr A, Rudnick B, Kloniecke E, Gomella LG. Hemorrhagic cystitis: a review of the literature and treatment options. Can J Urol. 2022 10; 29(5):11276-11283. PMID: 36245196.

Citations:
Gomella LG. The Rise of Self-Service Health Care in Urology and Other Specialties. Can J Urol. 2022 10; 29(5):11270-11271. PMID: 36245194.

Citations:
Gomella PT, Mark JR, Giri VN, Kelly WK, Gomella LG. Guidelines on Germline Testing for Urologic Tumor Syndromes. Eur Urol Focus. 2022 Jul 05. PMID: 35803854.

Citations:
Loeb S, Cheng HH, Leader A, Gross L, Nolasco TS, Byrne N, Wise DR, Hollifield L, Brown LH, Slater E, Pieczonka C, Gomella LG, Kelly WK, Trabulsi EJ, Handley N, Lallas CD, Chandrasekar T, Mille P, Mann M, Mark JR, Brown G, Chopra S, Wasserman J, Phillips J, Somers P, Giri VN. Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing. Contemp Clin Trials. 2022 Jun 13; 106821. PMID: 35710085.

Citations:
Hall WA, Karrison TG, Rosenthal SA, Amin MB, Gomella LG, Purdy JA, Sartor AO, Michalski JM, Garzotto MG, Bergom CR, Jani AB, Lawton CAF, Simko JP, Moore JK, Gore EM, Lee WR, Nguyen PL, Danielson BL, Sandler HM, Feng FY. The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High Risk Prostate Cancer: A Validation Study from NRG/RTOG 0521. Int J Radiat Oncol Biol Phys. 2022 Jun 05. PMID: 35675855.

Citations:
Gomella LG. When is cancer not a cancer? The prostate cancer debate. Can J Urol. 2022 Jun; 29(3):11123-11124. PMID: 35691031.

Citations:
Pollack A, Karrison TG, Balogh AG, Gomella LG, Low DA, Bruner DW, Wefel JS, Martin AG, Michalski JM, Angyalfi SJ, Lukka H, Faria SL, Rodrigues GB, Beauchemin MC, Lee RJ, Seaward SA, Allen AM, Monitto DC, Seiferheld W, Sartor O, Feng F, Sandler HM. The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial. Lancet. 2022 05 14; 399(10338):1886-1901. PMID: 35569466.

Citations:
Dylgjeri E, Kothari V, Shafi AA, Semenova G, Gallagher PT, Guan YF, Pang A, Goodwin JF, Irani S, McCann JJ, Mandigo AC, Chand S, McNair CM, Vasilevskaya I, Schiewer MJ, Lallas CD, McCue PA, Gomella LG, Seifert EL, Carroll JS, Butler LM, Holst J, Kelly WK, Knudsen KE. A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration Resistant Prostate Cancer. Clin Cancer Res. 2022 Jan 25. PMID: 35078861.

Citations:
Nerli RB, Ghagane SC, Rangrez SS, Chandra S, Thakur ML, Gomella L. Author Reply Re: Nerli RB, Ghagane SC, Rangrez S, Chandra S, Thakur ML, Gomella L. Detection of bladder cancer using voided urine sample and by targeting genomic VPAC receptors. Indian J Urol 2021;37:345-9. Indian J Urol. 2022 Jan-Mar; 38(1):78-79. PMID: 35136304.

Citations:
Mitra AP, Narayan VM, Mokkapati S, Miest T, Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni J, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown GA, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole GL, Sankin AI, Boyd A, O'Donnell MA, Philipson R, Ylä-Herttuala S, Sawutz D, Parker NR, McConkey DJ, Dinney CPN. Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial. Eur Urol. 2022 Mar; 81(3):223-228. PMID: 34933753.

Citations:
Gomella LG. Aligning Prostate Cancer Screening Recommendations for Patients and Provider. Can J Urol. 2021 Dec; 28(6):10878-10880. PMID: 34895390.

Citations:
Giri VN, Walker A, Gross L, Trabulsi EJ, Lallas CD, Kelly WK, Gomella LG, Fischer C, Loeb S. Helix: A Digital Tool to Address Provider Needs for Prostate Cancer Genetic Testing in Clinical Practice. Clin Genitourin Cancer. 2021 Nov 27. PMID: 35012874.

Citations:
Nerli RB, Ghagane SC, Bidi SR, Thakur ML, Gomella L. Voided urine test to diagnose prostate cancer: Preliminary report. Cytojournal. 2021; 18:26. PMID: 34754324.

Citations:
Nerli RB, Ghagane SC, Rangrez S, Chandra S, Thakur ML, Gomella L. Detection of bladder cancer using voided urine sample and by targeting genomic VPAC receptors. Indian J Urol. 2021 Oct-Dec; 37(4):345-349. PMID: 34759527.

Citations:
Glick L, Vincent SA, Squadron D, Han TM, Syed K, Danella JF, Ginzburg S, Guzzo TJ, Lanchoney T, Raman JD, Smaldone M, Uzzo RG, Tomaszweski JJ, Reese A, Singer EA, Jacobs B, Trabulsi EJ, Gomella LG, Mann MJ. EDITORIAL COMMENT. Urology. 2021 Sep; 155:18. PMID: 34489002.

Citations:
Chandrasekar T, Bowler N, Schneider A, Goldberg H, Mark JR, Trabulsi EJ, Lallas CD, Gomella LG. AUTHOR REPLY. Urology. 2021 Sep; 155:109. PMID: 34488992.

Citations:
Russo J, McDougall C, Bowler N, Shimada A, Gross L, Hyatt C, Kelly WK, Calvaresi A, Handley NR, Hirsch IH, Izes JK, Lallas CD, Mann M, Mark JR, Mille PJ, Preate D, Trabulsi EJ, Tsang M, Chandrasekar T, Weiner PR, Gomella LG, Giri VN. Pretest Genetic Education Video Versus Genetic Counseling for Men Considering Prostate Cancer Germline Testing: A Patient-Choice Study to Address Urgent Practice Needs. JCO Precis Oncol. 2021; 5. PMID: 34589662.

Citations:
Gomella LG. Surgical mesh: not as bad as you think. Can J Urol. 2021 Aug; 28(4):10733. PMID: 34378505.

Citations:
Gomella LG, Giri VN. Prostate Cancer Genetics: Changing the Paradigm of Care. Urol Clin North Am. 2021 Aug; 48(3):xiii-xiv. PMID: 34210497.

Citations:
Chandrasekar T, Bowler N, Schneider A, Goldberg H, Mark JR, Trabulsi EJ, Lallas CD, Gomella LG. Outcomes of Active Surveillance for Men With Intermediate Risk Prostate Cancer: A Population-Based Analysis. Urology. 2021 Sep; 155:101-109. PMID: 34186134.

Citations:
Chandrasekar T, Kelly WK, Gomella LG. Overview of Prostate Cancer Genetic Testing. Urol Clin North Am. 2021 Aug; 48(3):279-282. PMID: 34210484.

Citations:
Peters CJ, Turner CE, Chesnut GT, Giri VN, Gomella LG, Shriver CD, Dobi A. Philadelphia Prostate Cancer Genetic Consensus Conference 2019 and implications for military medicine. Can J Urol. 2021 06; 28(3):10659-10667. PMID: 34129457.

Citations:
Gomella LG. Keeping Our Morcellators Straight in Minimally Invasive Surgery. Can J Urol. 2021 06; 28(3):10652. PMID: 34129453.

Citations:
Glick L, Vincent SA, Squadrito D, Han TM, Syed K, Danella JF, Ginzburg S, Guzzo TJ, Lanchoney T, Raman JD, Smaldone M, Uzzo RG, Tomaszweski JJ, Reese A, Singer EA, Jacobs B, Trabulsi EJ, Gomella LG, Mann MJ. Preventing Prostate Biopsy Complications: to Augment or to Swab? Urology. 2021 Apr 17. PMID: 33878333.

Citations:
Thakur ML, Tripathi SK, Gomella LG, Salmanoglu E, Kim S, Kelly WK, Keith SW, Intenzo C, McCue P, Hoffman-Censits J, Trabulsi EJ. Imaging urothelial bladder cancer: A VPAC PET targeted approach. Can J Urol. 2021 Apr; 28(2):10596-10602. PMID: 33872557.

Citations:
Gomella LG. The Agony and Ecstasy of Prostate Cancer PSMA PET. Can J Urol. 2021 Apr; 28(2):10574-10575. PMID: 33872551.

Citations:
Gonzalez D, Mateo J, Stenzinger A, Rojo F, Shiller M, Wyatt AW, Penault-Llorca F, Gomella LG, Eeles R, Bjartell A. Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer. J Pathol Clin Res. 2021 Feb 25. PMID: 33630412.

Citations:
Handley NR, Feng FY, Guise TA, D'Andrea D, Kelly WK, Gomella LG. Preserving Well-being in Patients With Advanced and Late Prostate Cancer. Urology. 2020 Dec 26. PMID: 33373704.

Citations:
Gomella LG. 'Send me a picture of your urine': Telemedicine in Urology. Can J Urol. 2020 12; 27(6):10424-10425. PMID: 33325341.

Citations:
Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni J, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole GL, Sankin AI, Boyd A, O'Donnell MA, Sawutz D, Philipson R, Coll R, Narayan VM, Treasure FP, Yla-Herttuala S, Parker NR, Dinney CPN. Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial. Lancet Oncol. 2021 01; 22(1):107-117. PMID: 33253641.

Citations:
Chung PH, Leong JY, Teplitsky S, Shenot PJ, Das AK, Gomella LG. Next-generation DNA sequencing for infected genitourinary implants: How I do it. Can J Urol. 2020 10; 27(5):10418-10423. PMID: 33049198.

Citations:
Crawford ED, Andriole G, Freedland SJ, Garnick M, Gomella LG, Henderson J, Higano CT, Kader AK, Kane C, Keane TE, Koo PJ, Petrylak DP, Reiter RE, Slovin SF, Yu EY. Evolving understanding and categorization of prostate cancer: preventing progression to metastatic castration-resistant prostate cancer: RADAR IV. Can J Urol. 2020 10; 27(5):10352-10362. PMID: 33049187.

Citations:
Gomella LG. COVID-19 and The Prostate Cancer Connection. Can J Urol. 2020 10; 27(5):10346. PMID: 33049184.

Citations:
Morgans AK, Shore N, Cope D, McNatty A, Moslehi J, Gomella L, Sartor O. Androgen receptor inhibitor treatments: Cardiovascular adverse events and comorbidity considerations in patients with non-metastatic prostate cancer. Urol Oncol. 2021 Jan; 39(1):52-62. PMID: 32958445.

Citations:
Gomella LG. Editorial Commentary. Urol Pract. 2020 Nov; 7(6):540. PMID: 37287181.

Citations:
Antonarakis ES, Gomella LG, Petrylak DP. When and How to Use PARP Inhibitors in Prostate Cancer: A Systematic Review of the Literature with an Update on On-Going Trials. Eur Urol Oncol. 2020 Aug 17. PMID: 32814685.

Citations:
Uhr A, Glick L, Gomella LG. An overview of biomarkers in the diagnosis and management of prostate cancer. Can J Urol. 2020 Aug; 27(S3):24-27. PMID: 32875999.

Citations:
Giri VN, Knudsen KE, Kelly WK, Cheng HH, Cooney KA, Cookson MS, Dahut W, Weissman S, Soule HR, Petrylak DP, Dicker AP, AlDubayan SH, Toland AE, Pritchard CC, Pettaway CA, Daly MB, Mohler JL, Parsons JK, Carroll PR, Pilarski R, Blanco A, Woodson A, Rahm A, Taplin ME, Polascik TJ, Helfand BT, Hyatt C, Morgans AK, Feng F, Mullane M, Powers J, Concepcion R, Lin DW, Wender R, Mark JR, Costello A, Burnett AL, Sartor O, Isaacs WB, Xu J, Weitzel J, Andriole GL, Beltran H, Briganti A, Byrne L, Calvaresi A, Chandrasekar T, Chen DYT, Den RB, Dobi A, Crawford ED, Eastham J, Eggener S, Freedman ML, Garnick M, Gomella PT, Handley N, Hurwitz MD, Izes J, Karnes RJ, Lallas C, Languino L, Loeb S, Lopez AM, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann M, Mille P, Miner MM, Morgan T, Moreno J, Mucci L, Myers RE, Nielsen SM, O'Neil B, Pinover W, Pinto P, Poage W, Raj GV, Rebbeck TR, Ryan C, Sandler H, Schiewer M, Scott EMD, Szymaniak B, Tester W, Trabulsi EJ, Vapiwala N, Yu EY, Zeigler-Johnson C, Gomella LG. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019. J Clin Oncol. 2020 Jun 09; JCO2000046. PMID: 32516092.

Citations:
Gomella LG. Burnout in Urology and the Hidden Workplace Dangers. Can J Urol. 2020 Jun; 27(3):10199-10200. PMID: 32544040.

Citations:
Den RB, Greenspan J, Doyle LA, Harrison AS, Peng C, Williams NL, Lallas CD, Trabulsi EJ, Gomella LG, Hurwitz MD, Leiby B, Dicker AP. A phase IB clinical trial of 15 Gy HDR brachytherapy followed by hypofractionated/SBRT in the management of intermediate-risk prostate cancer. Brachytherapy. 2020 Mar 23. PMID: 32217038.

Citations:
Carceles-Cordon M, Kelly WK, Gomella L, Knudsen KE, Rodriguez-Bravo V, Domingo-Domenech J. Cellular rewiring in lethal prostate cancer: the architect of drug resistance. Nat Rev Urol. 2020 Mar 16. PMID: 32203305.

Citations:
Chandrasekar T, Han TM, Glick L, Leong JY, Teplitsky S, Noorani R, Goldberg H, Klaassen Z, Wallis CJD, Mark JR, Trabulsi EJ, Lallas CD, Gomella LG. Setting the Standards: Examining Research Productivity Among Academic Urologists in the USA and Canada in 2019. Eur Urol Focus. 2020 Feb 26. PMID: 32113885.

Citations:
Yazdi H, Restrepo C, Foltz C, Hammad M, Chung PH, Gomella LG, Parvizi J. Symptomatic Benign Prostatic Hyperplasia: A Risk Factor for Periprosthetic Joint Infection in Male Patients. J Bone Joint Surg Am. 2020 Feb 20. PMID: 32079872.

Citations:
Lin J, Den RB, Greenspan J, Showalter TN, Hoffman-Censits JH, Lallas CD, Trabulsi EJ, Gomella LG, Hurwitz MD, Leiby B, Dicker AP, Kelly WK. Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys. 2020 Feb 03. PMID: 32029346.

Citations:
Gomella LG. Boosting Free Testosterone With OTC Natural Supplements: Be Careful What You Wish For. Can J Urol. 2020 Feb; 27(1):10067. PMID: 32065859.

Citations:
Mann M, Calio BP, Mark JR, Chelluri R, Hufnagel E, Reese A, Lallas CD, Trabulsi EJ, Chandrasekar T, Shenot PJ, Halpern E, Gomella LG. Hospital-specific antibiograms and antibiotic prophylaxis for prostate biopsies: a reexamination of AUA recommendations. Can J Urol. 2020 Feb; 27(1):10099-10104. PMID: 32065866.

Citations:
Marascio J, Spratt DE, Zhang J, Trabulsi EJ, Le T, Sedzorme WS, Beeler WH, Davicioni E, Dabbas B, Lin DW, Gore JL, Bloom M, Mann M, Mark JR, Calvaresi A, Godwin JL, McCue P, Hurwitz MD, Kelly WK, Lallas CD, Knudsen KE, Gomella LG, Dicker AP, Den RB. Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy. Prostate Cancer Prostatic Dis. 2019 Nov 12. PMID: 31719663.

Citations:
Leong JY, Herrera-Caceres JO, Goldberg H, Tham E, Teplitsky S, Gomella LG, Trabulsi EJ, Lallas CD, Fleshner NE, Tilki D, Chandrasekar T. Questioning the Status Quo: Should Gleason Grade Group 1 Prostate Cancer be Considered a "Negative Core" in Pre-Radical Prostatectomy Risk Nomograms? An International Multicenter Analysis. Urology. 2019 Nov 06. PMID: 31705947.

Citations:
Leong JY, Herrera-Caceres JO, Goldberg H, Tham E, Teplitsky S, Gomella LG, Fleshner NE, Lallas CD, Trabulsi EJ, Chandrasekar T. Incorporating mpMRI biopsy data into established pre-RP nomograms: potential impact of an increasingly common clinical scenario. Ther Adv Urol. 2019 Jan-Dec; 11:1756287219882809. PMID: 31662795.

Citations:
Gomella LG. Should Urologists Ask Their Adult Patients If They Were Premature? Can J Urol. 2019 Oct; 26(5):9905. PMID: 31629437.

Citations:
Gomella LG, Knudsen KE, Giri VN. Introduction to the 2019 Philadelphia Prostate Cancer Consensus Program: 'Implementation of Genetic Testing for Inherited Prostate Cancer'. Can J Urol. 2019 Oct; 26(5S2):1-4. PMID: 31629412.

Citations:
Hamstra DA, Pugh SL, Lepor H, Rosenthal SA, Pienta KJ, Gomella L, Peters C, D'Souza DP, Zeitzer KL, Jones CU, Hall WA, Horwitz E, Pisansky TM, Souhami L, Hartford AC, Dominello M, Feng F, Sandler HM. Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902. Radiother Oncol. 2019 Sep 17. PMID: 31540746.

Citations:
Lu-Yao G, Nikita N, Keith SW, Nightingale G, Gandhi K, Hegarty SE, Rebbeck TR, Chapman A, Kantoff PW, Cullen J, Gomella L, Kelly WK. Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities. Eur Urol. 2019 Aug 02. PMID: 31420248.

Citations:
Gomella LG. Viral Therapy for Bladder Cancer: Everything Old is New Again. Can J Urol. 2019 Aug; 26(4):9802. PMID: 31469632.

Citations:
Trabulsi EJ, Calio BP, Kamel SI, Gomella LG, Forsberg F, McCue P, Halpern EJ. Prostate Contrast Enhanced Transrectal Ultrasound (CE-TRUS) Evaluation of the Prostate with Whole Mount Prostatectomy Correlation. Urology. 2019 Aug 01. PMID: 31377256.

Citations:
Dylgjeri E, McNair C, Goodwin JF, Raymon HK, McCue PA, Shafi AA, Leiby BE, de Leeuw R, Kothari V, McCann JJ, Mandigo AC, Chand SN, Schiewer MJ, Brand LJ, Vasilevskaya I, Gordon N, Laufer TS, Gomella LG, Lallas CD, Trabulsi EJ, Feng FY, Filvaroff EH, Hege K, Rathkopf D, Knudsen KE. Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic Strategies. Clin Cancer Res. 2019 Jul 02. PMID: 31266833.

Citations:
Chandrasekar T, Gross L, Gomella LG, Hegarty SE, Leong JY, Giri VN. Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men. Eur Urol Oncol. 2019 Jul 02. PMID: 31278035.

Citations:
Moreno JG, Gomella LG. Evolution of the Liquid Biopsy in Metastatic Prostate Cancer. Urology. 2019 Jun 14. PMID: 31207303.

Citations:
Leong JY, Capella C, Teplitsky S, Gomella LG, Trabulsi EJ, Lallas CD, Chandrasekar T. Impact of Tumor Regional Involvement on Active Surveillance Outcomes: Validation of the Cumulative Cancer Location Metric in a US Population. Eur Urol Focus. 2019 May 18. PMID: 31109856.

Citations:
Giri VN, Hyatt C, Gomella LG. Germline Testing for Men With Prostate Cancer: Navigating an Expanding New World of Genetic Evaluation for Precision Therapy and Precision Management. J Clin Oncol. 2019 Apr 12; JCO1802181. PMID: 30978156.

Citations:
Gomella LG. Is BCG a Hazardous Drug? Ask NIOSH, OSHA, and the USP. Can J Urol. 2019 Apr; 26(2):9687-9689. PMID: 31012830.

Citations:
Leong JY, Calio B, Shah M, Sullivan P, Trabulsi EJ, Gomella LG, Lallas CD. Overlapping surgeries: defining the 'critical portions' of the procedure. Can J Urol. 2019 Apr; 26(2):9694-9698. PMID: 31012832.

Citations:
Rosenthal SA, Hu C, Sartor O, Gomella LG, Amin MB, Purdy J, Michalski JM, Garzotto MG, Pervez N, Balogh AG, Rodrigues GB, Souhami L, Reaume MN, Williams SG, Hannan R, Horwitz EM, Raben A, Peters CA, Feng FY, Shipley WU, Sandler HM. Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial. J Clin Oncol. 2019 Mar 12; JCO1802158. PMID: 30860948.

Citations:
Schiewer MJ, Mandigo AC, Gordon N, Huang F, Gaur S, de Leeuw R, Zhao SG, Evans J, Han S, Parsons T, Birbe R, McCue P, McNair C, Chand SN, Cendon-Florez Y, Gallagher P, McCann JJ, Poudel Neupane N, Shafi AA, Dylgjeri E, Brand LJ, Visakorpi T, Raj GV, Lallas CD, Trabulsi EJ, Gomella LG, Dicker AP, Kelly WK, Leiby BE, Knudsen B, Feng FY, Knudsen KE. PARP-1 regulates DNA repair factor availability. EMBO Mol Med. 2018 12; 10(12). PMID: 30467127.

Citations:
Gomella LG. Before Ordering a Genetic Test Get to Know GINA. Can J Urol. 2018 12; 25(6):9569. PMID: 30553279.

Citations:
Giri VN, Hegarty SE, Hyatt C, O'Leary E, Garcia J, Knudsen KE, Kelly WK, Gomella LG. Germline genetic testing for inherited prostate cancer in practice: Implications for genetic testing, precision therapy, and cascade testing. Prostate. 2019 Mar; 79(4):333-339. PMID: 30450585.

Citations:
Joseph JV, Brasacchio R, Fung C, Reeder J, Bylund K, Sahasrabudhe D, Yeh SY, Ghazi A, Fultz P, Rubens D, Wu G, Singer E, Schwarz E, Mohile S, Mohler J, Theodorescu D, Lee YF, Okunieff P, McConkey D, Rashid H, Chang C, Fradet Y, Guru K, Kukreja J, Sufrin G, Lotan Y, Bailey H, Noyes K, Schwartz S, Rideout K, Bratslavsky G, Campbell SC, Derweesh I, Abrahamsson PA, Soloway M, Gomella L, Golijanin D, Svatek R, Frye T, Lerner S, Palapattu G, Wilding G, Droller M, Trump D. A Festschrift in Honor of Edward M. Messing, MD, FACS. Bladder Cancer. 2018 Oct 03; 4(Suppl 1):S1-S43. PMID: 30443561.

Citations:
Centenera MM, Hickey TE, Jindal S, Ryan NK, Ravindranathan P, Mohammed H, Robinson JL, Schiewer MJ, Ma S, Kapur P, Sutherland PD, Hoffmann CE, Roehrborn CG, Gomella LG, Carroll JS, Birrell SN, Knudsen KE, Raj GV, Butler LM, Tilley WD. A patient-derived explant (PDE) model of hormone-dependent cancer. Mol Oncol. 2018 Sep; 12(9):1608-1622. PMID: 30117261.

Citations:
Rodriguez-Bravo V, Pippa R, Song WM, Carceles-Cordon M, Dominguez-Andres A, Fujiwara N, Woo J, Koh AP, Ertel A, Lokareddy RK, Cuesta-Dominguez A, Kim RS, Rodriguez-Fernandez I, Li P, Gordon R, Hirschfield H, Prats JM, Reddy EP, Fatatis A, Petrylak DP, Gomella L, Kelly WK, Lowe SW, Knudsen KE, Galsky MD, Cingolani G, Lujambio A, Hoshida Y, Domingo-Domenech J. Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import. Cell. 2018 Aug 23; 174(5):1200-1215.e20. PMID: 30100187.

Citations:
Crawford ED, Koo PJ, Shore N, Slovin SF, Concepcion RS, Freedland SJ, Gomella LG, Karsh L, Keane TE, Maroni P, Penson D, Petrylak DP, Ross A, Mouraviev V, Reiter RE, Divgi C, Yu EY. A Clinician's Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence [RADAR] III). J Urol. 2018 Aug 02. PMID: 30077557.

Citations:
Gomella LG. Should Urology Reconsider the Routine Use of Fluoroquinolones? Can J Urol. 2018 Aug; 25(4):9366. PMID: 30125512.

Citations:
Shafi AA, Schiewer MJ, de Leeuw R, Dylgjeri E, McCue PA, Shah N, Gomella LG, Lallas CD, Trabulsi EJ, Centenera MM, Hickey TE, Butler LM, Raj G, Tilley WD, Cukierman E, Knudsen KE. Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response. Eur Urol Oncol. 2018 Sep; 1(4):325-337. PMID: 30467556.

Citations:
Gomella LG. Prostate Cancer CRPC Stage M0 and M1: Do We Need Stage M0.5? Can J Urol. 2018 Apr; 25(2):9220. PMID: 29679997.

Citations:
Jacene H, Gomella L, Yu EY, Rohren EM. Hematologic Toxicity From Radium-223 Therapy for Bone Metastases in Castration-Resistant Prostate Cancer: Risk Factors and Practical Considerations. Clin Genitourin Cancer. 2018 Mar 23. PMID: 29678471.

Citations:
Mark JR, Kelly WK, Gomella LG. Multidisciplinary Clinical Treatment of Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2018 Mar 15. PMID: 29543958.

Citations:
Truong H, Gomella LG, Thakur ML, Trabulsi EJ. VPAC1-targeted PET/CT scan: improved molecular imaging for the diagnosis of prostate cancer using a novel cell surface antigen. World J Urol. 2018 Mar 14. PMID: 29541892.

Citations:
Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, Bekelman JE, Benson MC, Blanco A, Burnett A, Catalona WJ, Cooney KA, Cooperberg M, Crawford DE, Den RB, Dicker AP, Eggener S, Fleshner N, Freedman ML, Hamdy FC, Hoffman-Censits J, Hurwitz MD, Hyatt C, Isaacs WB, Kane CJ, Kantoff P, Karnes RJ, Karsh LI, Klein EA, Lin DW, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann MJ, Mark JR, McCue PA, Miner MM, Morgan T, Moul JW, Myers RE, Nielsen SM, Obeid E, Pavlovich CP, Peiper SC, Penson DF, Petrylak D, Pettaway CA, Pilarski R, Pinto PA, Poage W, Raj GV, Rebbeck TR, Robson ME, Rosenberg MT, Sandler H, Sartor O, Schaeffer E, Schwartz GF, Shahin MS, Shore ND, Shuch B, Soule HR, Tomlins SA, Trabulsi EJ, Uzzo R, Vander Griend DJ, Walsh PC, Weil CJ, Wender R, Gomella LG. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017. J Clin Oncol. 2018 Feb 01; 36(4):414-424. PMID: 29236593.

Citations:
Gomella LG. New Urologic Oncology Drugs and The New Toxicities. Can J Urol. 2017 Dec; 24(6):9075. PMID: 29260629.

Citations:
Gomella LG. Where have all the sperm gone? Can J Urol. 2017 10; 24(5):8972. PMID: 28971781.

Citations:
Glassman DT, Puri AK, Weingarten S, Hollander JE, Stepchin A, Trabulsi E, Gomella LG. Initial Experience with Telemedicine at a Single Institution. Urol Pract. 2018 Sep; 5(5):367-371. PMID: 37312348.

Citations:
Shore ND, Boorjian SA, Canter DJ, Ogan K, Karsh LI, Downs TM, Gomella LG, Kamat AM, Lotan Y, Svatek RS, Bivalacqua TJ, Grubb RL, Krupski TL, Lerner SP, Woods ME, Inman BA, Milowsky MI, Boyd A, Treasure FP, Gregory G, Sawutz DG, Yla-Herttuala S, Parker NR, Dinney CPN. Intravesical rAd-IFNa/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study. J Clin Oncol. 2017 Oct 20; 35(30):3410-3416. PMID: 28834453.

Citations:
Mark JR, Gomella LG. Nonpalpable Intratesticular Mass in a Young Man With a History of Contralateral Retractile Testis. Oncology (Williston Park). 2017 06 15; 31(6):484, 489-91. PMID: 28620904.

Citations:
Gomella LG. The Urology Guide to Coffee and Tea. Can J Urol. 2017 Jun; 24(3):8782-8783. PMID: 28646930.

Citations:
Giri VN, Obeid E, Gross L, Bealin L, Hyatt C, Hegarty SE, Montgomery S, Forman A, Bingler R, Kelly WK, Dicker AP, Winheld S, Trabulsi EJ, Chen DYT, Lallas CD, Allen BA, Daly MB, Gomella LG. Inherited Mutations in Men Undergoing Multigene Panel Testing for Prostate Cancer: Emerging Implications for Personalized Prostate Cancer Genetic Evaluation. JCO Precis Oncol. 2017 May; 1. PMID: 34164591.

Citations:
Tripathi SK, Kumar P, Trabulsi EJ, Kim S, McCue PA, Intenzo C, Berger A, Gomella L, Thakur ML. VPAC1 Targeted 64Cu-TP3805 kit preparation and its evaluation. Nucl Med Biol. 2017 Aug; 51:55-61. PMID: 28577428.

Citations:
Tanimoto R, Palladino C, Xu SQ, Buraschi S, Neill T, Gomella LG, Peiper SC, Belfiore A, Iozzo RV, Morrione A. The perlecan-interacting growth factor progranulin regulates ubiquitination, sorting, and lysosomal degradation of sortilin. Matrix Biol. 2017 Dec; 64:27-39. PMID: 28433812.

Citations:
Gomella LG. The Liquid Biopsy for Prostate Cancer 25 Years Later. Can J Urol. 2017 Apr; 24(2):8693-8694. PMID: 28436352.

Citations:
Crawford ED, Petrylak DP, Shore N, Saad F, Slovin SF, Vogelzang NJ, Keane TE, Koo PJ, Gomella LG, O'Sullivan JM, Tombal B, Concepcion RS, Sieber P, Stone NN, Finkelstein SE, Yu EY. The Role of Therapeutic Layering in Optimizing Treatment for Patients With Castration-resistant Prostate Cancer (Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence II). Urology. 2017 Jun; 104:150-159. PMID: 28302580.

Citations:
Trabulsi EJ, Tripathi SK, Gomella L, Solomides C, Wickstrom E, Thakur ML. Development of a voided urine assay for detecting prostate cancer non-invasively: a pilot study. BJU Int. 2017 Jun; 119(6):885-895. PMID: 28075510.

Citations:
Gomella LG, Mann MJ, Cleary RC, Hubosky SG, Bagley DH, Thumar AB, McCue PA, Lallas CD, Trabulsi EJ. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date. Can J Urol. 2017 Feb; 24(1):8620-8626. PMID: 28263126.

Citations:
Gomella LG. Prostate Cancer Statistics: Anything You Want Them To Be. Can J Urol. 2017 Feb; 24(1):8603-8604. PMID: 28263123.

Citations:
Truong H, Hegarty SE, Gomella LG, Kelly WK, Trabulsi EJ, Lallas CD, Giri VN. Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts. J Genet Couns. 2017 Jun; 26(3):548-555. PMID: 28101821.

Citations:
Gomella LG. Editorial Comment. J Urol. 2017 Mar; 197(3 Pt 1):601. PMID: 27992742.

Citations:
Gomella LG. Prostate, Breast and Ovarian Cancer Genetic Risk Assessment: Connecting the Dots. Can J Urol. 2016 Oct; 23(5):8429. PMID: 27705725.

Citations:
Kim H, Alshalalfa M, Hoffman-Censits J, Lallas CD, Davicioni E, Lin J, Birbe R, Erho N, Lehrer J, Ashab HA, Takhar M, Olson A, Lam LL, Kelly WK, Knudsen KE, Thangavel C, Seiler R, Feng FY, Schaeffer EM, Trabulsi EJ, Gomella LG, Hurwitz MD, Dicker AP, Den RB. Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report. Urol Case Rep. 2016 Nov; 9:51-54. PMID: 27713863.

Citations:
Ju X, Jiao X, Ertel A, Casimiro MC, Di Sante G, Deng S, Li Z, Di Rocco A, Zhan T, Hawkins A, Stoyanova T, Andò S, Fatatis A, Lisanti MP, Gomella LG, Languino LR, Pestell RG. v-Src Oncogene Induces Trop2 Proteolytic Activation via Cyclin D1. Cancer Res. 2016 Nov 15; 76(22):6723-6734. PMID: 27634768.

Citations:
Lallas CD, Scotland K, Zhang M, Schaeffer D, Calvaresi AE, Gomella L, Brown D, Shaw C, Trabulsi EJ. Clinical Influences in the Multidisciplinary Management of Small Renal Masses at a Tertiary Referral Center. Urol Pract. 2016 Nov; 3(6):468-474. PMID: 37592537.

Citations:
Gomella LG. Big Data Equals Big Challenges for Prostate Cancer. Can J Urol. 2016 Aug; 23(4):8329. PMID: 27544553.

Citations:
Crawford ED, Rosenberg MT, Partin AW, Cooperberg MR, Maccini M, Loeb S, Pettaway CA, Shore ND, Arangua P, Hoenemeyer J, Leveridge M, Leapman M, Pinto P, Thompson IM, Carroll P, Eastham J, Gomella L, Klein EA. An Approach Using PSA Levels of 1.5?ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care. Urology. 2016 Oct; 96:116-120. PMID: 27450937.

Citations:
Myers RE, Leader AE, Censits JH, Trabulsi EJ, Keith SW, Petrich AM, Quinn AM, Den RB, Hurwitz MD, Lallas CD, Hegarty SE, Dicker AP, Zeigler-Johnson CM, Giri VN, Ayaz H, Gomella LG. Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study. J Cancer Educ. 2016 Jul 15. PMID: 27418065.

Citations:
Buraschi S, Xu SQ, Stefanello M, Moskalev I, Morcavallo A, Genua M, Tanimoto R, Birbe R, Peiper SC, Gomella LG, Belfiore A, Black PC, Iozzo RV, Morrione A. Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatin. Oncotarget. 2016 Jun 28; 7(26):39980-39995. PMID: 27220888.

Citations:
Dan TD, Doyle L, Raval AJ, Pridjian A, Gomella LG, Den RB. Dosing, administration, and safety of radium-223: How I do it. Can J Urol. 2016 Jun; 23(3):8301-5. PMID: 27347625.

Citations:
Gomella LG. TV Drug Commercials: Keeping Physicians Informed. Can J Urol. 2016 Apr; 23(2):8188. PMID: 27085820.

Citations:
Giri VN, Gross L, Gomella LG, Hyatt C. How I Do It: Genetic counseling and genetic testing for inherited prostate cancer. Can J Urol. 2016 Apr; 23(2):8247-53. PMID: 27085833.

Citations:
Fizazi K, Chi KN, de Bono JS, Gomella LG, Miller K, Rathkopf DE, Ryan CJ, Scher HI, Shore ND, De Porre P, Londhe A, McGowan T, Pelhivanov N, Charnas R, Todd MB, Montgomery B. Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol. 2016 Sep; 70(3):438-44. PMID: 26965562.

Citations:
Gomella LG. Editorial Commentary. Urol Pract. 2016 May; 3(3):209. PMID: 37592520.

Citations:
Gomella LG. Punishing Physicians for PSA Screening. Can J Urol. 2015 Dec; 22(6):8042. PMID: 26688130.

Citations:
Tripathi S, Trabulsi EJ, Gomella L, Kim S, McCue P, Intenzo C, Birbe R, Gandhe A, Kumar P, Thakur M. VPAC1 Targeted (64)Cu-TP3805 Positron Emission Tomography Imaging of Prostate Cancer: Preliminary Evaluation in Man. Urology. 2016 Feb; 88:111-8. PMID: 26519886.

Citations:
Gomella LG. Robotic and Open Radical Prostatectomy: Celebrating Oncologic Equivalence. Can J Urol. 2015 Oct; 22(5):7942-3. PMID: 26432961.

Citations:
Talati PG, Gu L, Ellsworth EM, Girondo MA, Trerotola M, Hoang DT, Leiby B, Dagvadorj A, McCue PA, Lallas CD, Trabulsi EJ, Gomella L, Aplin AE, Languino L, Fatatis A, Rui H, Nevalainen MT. Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer. Am J Pathol. 2015 Sep; 185(9):2505-22. PMID: 26362718.

Citations:
Rosenthal SA, Hunt D, Sartor AO, Pienta KJ, Gomella L, Grignon D, Rajan R, Kerlin KJ, Jones CU, Dobelbower M, Shipley WU, Zeitzer K, Hamstra DA, Donavanik V, Rotman M, Hartford AC, Michalski J, Seider M, Kim H, Kuban DA, Moughan J, Sandler H. A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902. Int J Radiat Oncol Biol Phys. 2015 Oct 1; 93(2):294-302. PMID: 26209502.

Citations:
Goodwin JF, Kothari V, Drake JM, Zhao S, Dylgjeri E, Dean JL, Schiewer MJ, McNair C, Jones JK, Aytes A, Magee MS, Snook AE, Zhu Z, Den RB, Birbe RC, Gomella LG, Graham NA, Vashisht AA, Wohlschlegel JA, Graeber TG, Karnes RJ, Takhar M, Davicioni E, Tomlins SA, Abate-Shen C, Sharifi N, Witte ON, Feng FY, Knudsen KE. DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis. Cancer Cell. 2015 Jul 13; 28(1):97-113. PMID: 26175416.

Citations:
Chu FM, Sartor O, Gomella L, Rudo T, Somerville MC, Hereghty B, Manyak MJ. A randomised, double-blind study comparing the addition of bicalutamide with or without dutasteride to GnRH analogue therapy in men with non-metastatic castrate-resistant prostate cancer. Eur J Cancer. 2015 Aug; 51(12):1555-69. PMID: 26048455.

Citations:
Liao Z, Gu L, Vergalli J, Mariani SA, De Dominici M, Lokareddy RK, Dagvadorj A, Purushottamachar P, McCue PA, Trabulsi E, Lallas CD, Gupta S, Ellsworth E, Blackmon S, Ertel A, Fortina P, Leiby B, Xia G, Rui H, Hoang DT, Gomella LG, Cingolani G, Njar V, Pattabiraman N, Calabretta B, Nevalainen MT. Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia. Mol Cancer Ther. 2015 Aug; 14(8):1777-93. PMID: 26026053.

Citations:
Xu SQ, Buraschi S, Morcavallo A, Genua M, Shirao T, Peiper SC, Gomella LG, Birbe R, Belfiore A, Iozzo RV, Morrione A. A novel role for drebrin in regulating progranulin bioactivity in bladder cancer. Oncotarget. 2015 May 10; 6(13):10825-39. PMID: 25839164.

Citations:
George DJ, Nabhan C, DeVries T, Whitmore JB, Gomella LG. Survival Outcomes of Sipuleucel-T Phase III Studies: Impact of Control-Arm Cross-Over to Salvage Immunotherapy. Cancer Immunol Res. 2015 Sep; 3(9):1063-9. PMID: 25943532.

Citations:
Gomella LG. Editorial Commentary. Urol Pract. 2015 Jul; 2(4):198. PMID: 37559264.

Citations:
Tanimoto R, Fashola Y, Scotland KB, Calvaresi AE, Gomella LG, Trabulsi EJ, Lallas CD. Risk factors for biochemical recurrence after robotic assisted radical prostatectomy: a single surgeon experience. BMC Urol. 2015; 15(1):27. PMID: 25879548.

Citations:
Gomella LG. The testosterone storm. Can J Urol. 2015 Apr; 22(2):7677. PMID: 25891328.

Citations:
Dan TD, Eldredge-Hindy HB, Hoffman-Censits J, Lin J, Kelly WK, Gomella LG, Lallas CD, Trabulsi EJ, Hurwitz MD, Dicker AP, Den RB. Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen Therapies. Am J Clin Oncol. 2015 Feb 25. PMID: 25723740.

Citations:
Londin E, Loher P, Telonis AG, Quann K, Clark P, Jing Y, Hatzimichael E, Kirino Y, Honda S, Lally M, Ramratnam B, Comstock CE, Knudsen KE, Gomella L, Spaeth GL, Hark L, Katz LJ, Witkiewicz A, Rostami A, Jimenez SA, Hollingsworth MA, Yeh JJ, Shaw CA, McKenzie SE, Bray P, Nelson PT, Zupo S, Van Roosbroeck K, Keating MJ, Calin GA, Yeo C, Jimbo M, Cozzitorto J, Brody JR, Delgrosso K, Mattick JS, Fortina P, Rigoutsos I. Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs. Proc Natl Acad Sci U S A. 2015 Mar 10; 112(10):E1106-15. PMID: 25713380.

Citations:
de Leeuw R, Berman-Booty LD, Schiewer MJ, Ciment SJ, Den RB, Dicker AP, Kelly WK, Trabulsi EJ, Lallas CD, Gomella LG, Knudsen KE. Novel actions of next-generation taxanes benefit advanced stages of prostate cancer. Clin Cancer Res. 2015 Feb 15; 21(4):795-807. PMID: 25691773.

Citations:
Den RB, Yousefi K, Trabulsi EJ, Abdollah F, Choeurng V, Feng FY, Dicker AP, Lallas CD, Gomella LG, Davicioni E, Karnes RJ. Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy. J Clin Oncol. 2015 Mar 10; 33(8):944-51. PMID: 25667284.

Citations:
Gomella LG. What's wrong with the practice of medicine today? Can J Urol. 2015 Feb; 22(1):7589. PMID: 25694003.

Citations:
Mishra MV, Scher ED, Andrel J, Margules AC, Hegarty SE, Trabulsi EJ, Hyslop T, Den RB, Lallas CD, Gomella LG, Dicker AP, Showalter TN. Adjuvant Versus Salvage Radiation Therapy for Prostate Cancer Patients With Adverse Pathologic Features: Comparative Analysis of Long-term Outcomes. Am J Clin Oncol. 2015 Feb; 38(1):55-60. PMID: 24051934.

Citations:
Shore ND, Karsh L, Gomella LG, Keane TE, Concepcion RS, Crawford ED. Avoiding obsolescence in advanced prostate cancer management: a guide for urologists. BJU Int. 2015 Feb; 115(2):188-97. PMID: 25756134.

Citations:
Tanimoto R, Morcavallo A, Terracciano M, Xu SQ, Stefanello M, Buraschi S, Lu KG, Bagley DH, Gomella LG, Scotlandi K, Belfiore A, Iozzo RV, Morrione A. Sortilin regulates progranulin action in castration-resistant prostate cancer cells. Endocrinology. 2015 Jan; 1(1):58-70. PMID: 25365768.

Citations:
Pisansky TM, Hunt D, Gomella LG, Amin MB, Balogh AG, Chinn DM, Seider MJ, Duclos M, Rosenthal SA, Bauman GS, Gore EM, Rotman MZ, Lukka HR, Shipley WU, Dignam JJ, Sandler HM. Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910. J Clin Oncol. 2015 Feb 1; 33(4):332-9. PMID: 25534388.

Citations:
Gomella LG. When 4 does not mean 4: A patient portal lesson. Can J Urol. 2014 Dec; 21(6):7516. PMID: 25483755.

Citations:
Calvaresi AE, Trabulsi EJ, Sonzogni M, Gomella LG, Lallas CD, Wachsmuth KS. Implementing Hexaminolevulinate HCl Blue Light Cystoscopy: A Nursing Perspective. AORN J. 2014 Nov; 100(5):489-99. PMID: 25443119.

Citations:
Lallas CD, Fashola Y, Den RB, Gelpi-Hammerschmidt F, Calvaresi AE, McCue P, Birbe R, Gomella LG, Trabulsi EJ. Predictors of positive surgical margins after radical prostatectomy at a single institution: preoperative and pathologic factors, and the impact of surgeon variability and technique on incidence and location. Can J Urol. 2014 Oct; 21(5):7479-86. PMID: 25347375.

Citations:
Daneshmand S, Schuckman AK, Bochner BH, Cookson MS, Downs TM, Gomella LG, Grossman HB, Kamat AM, Konety BR, Lee CT, Pohar KS, Pruthi RS, Resnick MJ, Smith ND, Witjes JA, Schoenberg MP, Steinberg GD. Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA. Nat Rev Urol. 2014 Oct; 11(10):589-96. PMID: 25245244.

Citations:
Lin J, Zhan T, Duffy D, Hoffman-Censits J, Kilpatrick D, Trabulsi EJ, Lallas CD, Chervoneva I, Limentani K, Kennedy B, Kessler S, Gomella L, Antonarakis ES, Carducci MA, Force T, Kelly WK. A pilot phase II Study of digoxin in patients with recurrent prostate cancer as evident by a rising PSA. Am J Cancer Ther Pharmacol. 2014 Sep 7; 2(1):21-32. PMID: 25580468.

Citations:
Den RB, Feng FY, Showalter TN, Mishra MV, Trabulsi EJ, Lallas CD, Gomella LG, Kelly WK, Birbe RC, McCue PA, Ghadessi M, Yousefi K, Davicioni E, Knudsen KE, Dicker AP. Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy. Int J Radiat Oncol Biol Phys. 2014 Aug 1; 89(5):1038-46. PMID: 25035207.

Citations:
Andriole GL, Bostwick DG, Gomella LG, Marberger M, Montorsi F, Tammela TL, Tindall DJ, Fowler IL, Garges HP, Wilson TH, Castro R. Modeling and Analysis of Gleason Score 8-10 Prostate Cancers in the REDUCE Study. Urology. 2014 Aug; 84(2):393-9. PMID: 24916669.

Citations:
Gomella LG. Prostate cancer and prostatocystitis: Equal in the eyes of ICD-10. Can J Urol. 2014 Jun; 21(4):7330-1. PMID: 25171273.

Citations:
Gomella LG. Clinical Trials: Naming Confusion or YABA? Can J Urol. 2014 Jun; 21(3):7255. PMID: 24978352.

Citations:
Gomella LG. Recommendations for adjuvant post prostatectomy radiation. Can J Urol. 2014 Jun; 21(3):7298. PMID: 24978360.

Citations:
Gomella LG. Prostate cancer: Alcohol, cancer and 5a-reductase inhibitors-is there a link? Nat Rev Urol. 2014 May; 11(5):253-4. PMID: 24776974.

Citations:
Witjes JA, Gomella LG, Stenzl A, Chang SS, Zaak D, Grossman HB. Safety of hexaminolevulinate for blue light cystoscopy in bladder cancer. A combined analysis of the trials used for registration and postmarketing data. Urology. 2014 Jul; 84(1):122-6. PMID: 24768013.

Citations:
Gomella LG, Petrylak DP, Shayegan B. Current management of advanced and castration resistant prostate cancer. Can J Urol. 2014 Apr; 21(2 Supp 1):1-6. PMID: 24775717.

Citations:
Gomella LG, Gelpi-Hammerschmidt F, Kundavram C. Practical guide to immunotherapy in castration resistant prostate cancer: the use of sipuleucel-T immunotherapy. Can J Urol. 2014 Apr; 21(2 Supp 1):48-56. PMID: 24775724.

Citations:
Gomella LG. Prostate cancer genomics: understanding the new landscape. Can J Urol. 2014 Feb; 21(1):7091. PMID: 24529006.

Citations:
Crawford ED, Stone NN, Yu EY, Koo PJ, Freedland SJ, Slovin SF, Gomella LG, Berger ER, Keane TE, Sieber P, Shore ND, Petrylak DP. Challenges and recommendations for early identification of metastatic disease in prostate cancer. Urology. 2014 Mar; 83(3):664-9. PMID: 24411213.

Citations:
Mishra MV, Shen X, Den RB, Champ CE, Trabulsi EJ, Lallas CD, Gomella LG, Dicker AP, Showalter TN. Patterns of Care for Elderly Men Diagnosed With Favorable-risk Prostate Cancer From 2004 to 2008: A Population-based Analysis. Am J Clin Oncol. 2013 Dec; 36(6):606-11. PMID: 22892435.

Citations:
Gomella LG. Prostate cancer: a high value target for cost containment. Can J Urol. 2013 Oct; 20(5):6888. PMID: 24128823.

Citations:
Morgan MA, Roberts NR, Pino LA, Trabulsi EJ, Brown DB, Gomella LG, Lallas CD. Percutaneous cryoablation for recurrent low grade renal cell carcinoma after failed nephron-sparing surgery. Can J Urol. 2013 Oct; 20(5):6933-7. PMID: 24128832.

Citations:
Ismail MT, Gomella LG. Transrectal prostate biopsy. Urol Clin North Am. 2013 Nov; 40(4):457-72. PMID: 24182969.

Citations:
Mishra MV, Bennett M, Vincent A, Lee OT, Lallas CD, Trabulsi EJ, Gomella LG, Dicker AP, Showalter TN. Identifying barriers to patient acceptance of active surveillance: content analysis of online patient communications. PLoS One. 2013; 8(9):e68563. PMID: 24039699.

Citations:
Zaorsky NG, Harrison AS, Trabulsi EJ, Gomella LG, Showalter TN, Hurwitz MD, Dicker AP, Den RB. Evolution of advanced technologies in prostate cancer radiotherapy. Nat Rev Urol. 2013 Oct; 10(10):565-79. PMID: 24018567.

Citations:
Gu L, Liao Z, Hoang DT, Dagvadorj A, Gupta S, Blackmon S, Ellsworth E, Talati P, Leiby B, Zinda M, Lallas CD, Trabulsi EJ, McCue P, Gomella L, Huszar D, Nevalainen MT. Pharmacologic inhibition of Jak2-Stat5 signaling By Jak2 inhibitor AZD1480 potently suppresses growth of both primary and castrate-resistant prostate cancer. Clin Cancer Res. 2013 Oct 15; 19(20):5658-74. PMID: 23942095.

Citations:
Gomella LG. Preventing and managing PSA recurrence following radical prostatectomy. Can J Urol. 2013 Jun; 20(3):6755. PMID: 23783042.

Citations:
Dicker AP, Gomella LG, Kevin Kelly W. Introduction: the changing landscape of prostate cancer. Semin Oncol. 2013 Jun; 40(3):241-3. PMID: 23806490.

Citations:
Healy KA, Gomella LG. Retropubic, laparoscopic, or robotic radical prostatectomy: is there any real difference? Semin Oncol. 2013 Jun; 40(3):286-96. PMID: 23806494.

Citations:
Haddad BR, Gu L, Mirtti T, Dagvadorj A, Vogiatzi P, Hoang DT, Bajaj R, Leiby B, Ellsworth E, Blackmon S, Ruiz C, Curtis M, Fortina P, Ertel A, Liu C, Rui H, Visakorpi T, Bubendorf L, Lallas CD, Trabulsi EJ, McCue P, Gomella L, Nevalainen MT. STAT5A/B Gene Locus Undergoes Amplification during Human Prostate Cancer Progression. Am J Pathol. 2013 Jun; 182(6):2264-75. PMID: 23660011.

Citations:
Gomella LG. Actos, slings, finasteride, and the vaccine compensation solution. Can J Urol. 2013 Apr; 20(2):6668. PMID: 23587504.

Citations:
Bjurlin MA, Carter HB, Schellhammer P, Cookson MS, Gomella LG, Troyer D, Wheeler TM, Schlossberg S, Penson DF, Taneja SS. Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing. J Urol. 2013 Jun; 189(6):2039-46. PMID: 23485507.

Citations:
Gomella LG, Oliver Sartor A. The current role and limitations of surrogate endpoints in advanced prostate cancer. Urol Oncol. 2014 Jan; 32(1):28.e1-9. PMID: 23433893.

Citations:
Gomella LG. CAUTI and Readmission Penalties: Urologists Beware. Can J Urol. 2013 Feb; 20(1):6592. PMID: 23433126.

Citations:
Zaorsky NG, Studenski MT, Dicker AP, Gomella L, Den RB. Stereotactic body radiation therapy for prostate cancer: Is the technology ready to be the standard of care? Cancer Treat Rev. 2013 May; 39(3):212-8. PMID: 23218442.

Citations:
Gomella LG. Circumcision: a spiritual, medical or criminal act? Can J Urol. 2012 Dec; 19(6):6530. PMID: 23228286.

Citations:
Schiewer MJ, Goodwin JF, Han S, Brenner JC, Augello MA, Dean JL, Liu F, Planck JL, Ravindranathan P, Chinnaiyan AM, McCue P, Gomella LG, Raj GV, Dicker AP, Brody JR, Pascal JM, Centenera MM, Butler LM, Tilley WD, Feng FY, Knudsen KE. Dual roles of PARP-1 promote cancer growth and progression. Cancer Discov. 2012 Dec; 2(12):1134-49. PMID: 22993403.

Citations:
Halpern EJ, Gomella LG, Forsberg F, McCue PA, Trabulsi EJ. Contrast enhanced transrectal ultrasound for the detection of prostate cancer: a randomized, double-blind trial of dutasteride pretreatment. J Urol. 2012 Nov; 188(5):1739-45. PMID: 22998915.

Citations:
Gomella LG. Heath care reform: the carrot, the stick and the hippocratic oath. Can J Urol. 2012 Aug; 19(4):6324. PMID: 22892252.

Citations:
Champ CE, Hegarty SE, Shen X, Mishra MV, Dicker AP, Trabulsi EJ, Lallas CD, Gomella LG, Hyslop T, Showalter TN. Prognostic factors and outcomes after definitive treatment of female urethral cancer: a population-based analysis. Urology. 2012 Aug; 80(2):374-81. PMID: 22857759.

Citations:
Rove KO, Debruyne FM, Djavan B, Gomella LG, Koul HK, Lucia MS, Petrylak DP, Shore ND, Stone NN, Crawford ED. Role of testosterone in managing advanced prostate cancer. Urology. 2012 Oct; 80(4):754-62. PMID: 22795376.

Citations:
Genua M, Xu SQ, Buraschi S, Peiper SC, Gomella LG, Belfiore A, Iozzo RV, Morrione A. Proline-rich tyrosine kinase 2 (Pyk2) regulates IGF-I-induced cell motility and invasion of urothelial carcinoma cells. PLoS One. 2012; 7(6):e40148. PMID: 22859931.

Citations:
Gomella LG. Can anyone spare a little indigo carmine? The drug shortage crisis. Can J Urol. 2012 Jun; 19(3):6238. PMID: 22704304.

Citations:
Gomella LG. Prostate cancer: The benefits of multidisciplinary prostate cancer care. Nat Rev Urol. 2012 Jul; 9(7):360-2. PMID: 22565373.

Citations:
Kelly DC, Margules AC, Kundavaram CR, Narins H, Gomella LG, Trabulsi EJ, Lallas CD. Face, content, and construct validation of the Da Vinci Skills Simulator. Urology. 2012 May; 79(5):1068-72. PMID: 22546387.

Citations:
Gomella LG. The quest for the perfect prostate biopsy continues. J Urol. 2012 Jun; 187(6):1954-5. PMID: 22503025.

Citations:
Kleinmann N, Zaorsky NG, Showalter TN, Gomella LG, Lallas CD, Trabulsi EJ. The effect of ethnicity and sexual preference on prostate-cancer-related quality of life. Nat Rev Urol. 2012 May; 9(5):258-65. PMID: 22487871.

Citations:
Mark JR, Gelpi-Hammerschmidt F, Trabulsi EJ, Gomella LG. Blue light cystoscopy for detection and treatment of non-muscle invasive bladder cancer. Can J Urol. 2012 Apr; 19(2):6227-31. PMID: 22512972.

Citations:
Gomella LG. Editorial: Renaming low risk prostate cancer: proceed cautiously. Can J Urol. 2012 Feb; 19(1):6069. PMID: 22316505.

Citations:
Kelly WK, Gomella LG. Androgen deprivation therapy and competing risks. JAMA. 2011 Dec 7; 306(21):2382-3. PMID: 22147384.

Citations:
Gomella LG. Celebrating the death of PSA screening? Can J Urol. 2011 Dec; 18(6):5987. PMID: 22166323.

Citations:
Djavan B, Eastham J, Gomella L, Tombal B, Taneja S, Dianat SS, Kazzazi A, Shore N, Abrahamsson PA, Cheetham P, Moul J, Lepor H, Crawford ED. Testosterone in prostate cancer: the Bethesda consensus. BJU Int. 2012 Aug; 110(3):344-52. PMID: 22129242.

Citations:
Moul JW, Evans CP, Gomella LG, Roach M, Dreicer R. Traditional approaches to androgen deprivation therapy. Urology. 2011 Nov; 78(5 Suppl):S485-93. PMID: 22054920.

Citations:
Miller-Samuel S, Rosenberg A, Berger A, Gomella L, Loren D, Morris GJ. BRCA1 and BRCA2 variants of uncertain significance. Part two: medical management. Semin Oncol. 2011 Oct; 38(5):605-11. PMID: 21943665.

Citations:
Eldredge HB, Studenski M, Keith SW, Trabulsi E, Lallas CD, Gomella LG, Dicker AP, Showalter TN. Post-prostatectomy image-guided radiation therapy: evaluation of toxicity and inter-fraction variation using online cone-beam CT. J Med Imaging Radiat Oncol. 2011 Oct; 55(5):507-15. PMID: 22008172.

Citations:
Gomella LG. How many clicks does it take to get to the middle of an EHR? Can J Urol. 2011 Oct; 18(5):5860. PMID: 22018145.

Citations:
Gomella LG, Liu XS, Trabulsi EJ, Kelly WK, Myers R, Showalter T, Dicker A, Wender R. Screening for prostate cancer: the current evidence and guidelines controversy. Can J Urol. 2011 Oct; 18(5):5875-83. PMID: 22018148.

Citations:
Gomella LG. Editor's note: Re: Screening for prostate cancer: the current evidence and guidelines controversy. Can J Urol. 2011 Oct; 18(5):5883. PMID: 22018149.

Citations:
Trabulsi EJ, Zola JC, Colon-Herdman A, Heckman JE, Gomella LG, Lallas CD. Minimally invasive radical prostatectomy: transition from pure laparoscopic to robotic-assisted radical prostatectomy. Arch Esp Urol. 2011 Oct; 64(8):823-9. PMID: 22052763.

Citations:
Gomella LG. The prostate cancer unit: a multidisciplinary approach for which the time has arrived. Eur Urol. 2011 Dec; 60(6):1197-9. PMID: 21871712.

Citations:
Iozzo RV, Buraschi S, Genua M, Xu SQ, Solomides CC, Peiper SC, Gomella LG, Owens RC, Morrione A. Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signaling. J Biol Chem. 2011 Oct 7; 286(40):34712-21. PMID: 21840990.

Citations:
Gomella LG, Gelpi F, Kelly WK. New treatment options for castrate-resistant prostate cancer: a urology perspective. Can J Urol. 2011 Aug; 18(4):5767-77. PMID: 21854708.

Citations:
Gomella LG. Name that prostate cancer drug. Can J Urol. 2011 Jun; 18(3):5666. PMID: 21703036.

Citations:
Ismail M, Ferroni M, Gomella LG. Androgen suppression strategies for prostate cancer: is there an ideal approach? Curr Urol Rep. 2011 Jun; 12(3):188-96. PMID: 21384154.

Citations:
Showalter TN, Ohri N, Teti KG, Foley KA, Keith SW, Trabulsi EJ, Lallas CD, Dicker AP, Hoffman-Censits J, Pizzi LT, Gomella LG. Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy. Int J Radiat Oncol Biol Phys. 2012 Feb 1; 82(2):e233-8. PMID: 21605945.

Citations:
Fassan M, D'Arca D, Letko J, Vecchione A, Gardiman MP, McCue P, Wildemore B, Rugge M, Shupp-Byrne D, Gomella LG, Morrione A, Iozzo RV, Baffa R. Mitostatin is down-regulated in human prostate cancer and suppresses the invasive phenotype of prostate cancer cells. PLoS One. 2011; 6(5):e19771. PMID: 21573075.

Citations:
Lawton CA, Hunt D, Lee WR, Gomella L, Grignon D, Gillin M, Morton G, Pisansky TM, Sandler H. Long-term results of a phase II trial of ultrasound-guided radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (RTOG 98-05). Int J Radiat Oncol Biol Phys. 2011 Sep 1; 81(1):1-7. PMID: 21470793.

Citations:
Liu XS, Folia C, Gomella LG. Pharmacology for common urologic diseases: 2011 review for the primary care physician. Can J Urol. 2011 Apr; 18 Suppl:24-38. PMID: 21501548.

Citations:
Gomella LG. Editorial: do you trust your testosterone level? Can J Urol. 2011 Apr; 18(2):5581. PMID: 21504643.

Citations:
Gomella LG. Teaching old prostate drugs new tricks in the battle against prostate cancer. Can J Urol. 2011 Feb; 18(1):5500. PMID: 21333039.

Citations:
Sharma A, Yeow WS, Ertel A, Coleman I, Clegg N, Thangavel C, Morrissey C, Zhang X, Comstock CE, Witkiewicz AK, Gomella L, Knudsen ES, Nelson PS, Knudsen KE. The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression. J Clin Invest. 2010 Dec; 120(12):4478-92. PMID: 21099110.

Citations:
Andriole GL, Bostwick D, Brawley OW, Gomella L, Marberger M, Montorsi F, Pettaway C, Tammela TL, Teloken C, Tindall D, Freedland SJ, Somerville MC, Wilson TH, Fowler I, Castro R, Rittmaster RS. The effect of dutasteride on the usefulness of prostate specific antigen for the diagnosis of high grade and clinically relevant prostate cancer in men with a previous negative biopsy: results from the REDUCE study. J Urol. 2011 Jan; 185(1):126-31. PMID: 21074214.

Citations:
Gomella LG, Lin J, Hoffman-Censits J, Dugan P, Guiles F, Lallas CD, Singh J, McCue P, Showalter T, Valicenti RK, Dicker A, Trabulsi EJ. Enhancing prostate cancer care through the multidisciplinary clinic approach: a 15-year experience. J Oncol Pract. 2010 Nov; 6(6):e5-e10. PMID: 21358951.

Citations:
Gomella LG. Male enhancement products: kudos to the FDA. Can J Urol. 2010 Oct; 17(5):5343. PMID: 20974023.

Citations:
Lallas CD, Pe ML, Thumar AB, Chandrasekar T, Lee FC, McCue P, Gomella LG, Trabulsi EJ. Comparison of lymph node yield in robot-assisted laparoscopic prostatectomy with that in open radical retropubic prostatectomy. BJU Int. 2011 Apr; 107(7):1136-40. PMID: 20825403.

Citations:
Trabulsi EJ, Sackett D, Gomella LG, Halpern EJ. Enhanced transrectal ultrasound modalities in the diagnosis of prostate cancer. Urology. 2010 Nov; 76(5):1025-33. PMID: 20719368.

Citations:
Singh J, Trabulsi EJ, Gomella LG. Is there an optimal management for localized prostate cancer? Clin Interv Aging. 2010; 5:187-97. PMID: 20711438.

Citations:
Gomella LG, Singh J, Lallas C, Trabulsi EJ. Hormone therapy in the management of prostate cancer: evidence-based approaches. Ther Adv Urol. 2010 Aug; 2(4):171-81. PMID: 21789093.

Citations:
Trabulsi EJ, Patel J, Viscusi ER, Gomella LG, Lallas CD. Preemptive multimodal pain regimen reduces opioid analgesia for patients undergoing robotic-assisted laparoscopic radical prostatectomy. Urology. 2010 Nov; 76(5):1122-4. PMID: 20570321.

Citations:
Gomella LG. Prostate cancer chemoprevention: more than meets the eye. Can J Urol. 2010 Jun; 17(3):5148. PMID: 20566004.

Citations:
Singh J, Trabulsi EJ, Gomella LG. The quality-of-life impact of prostate cancer treatments. Curr Urol Rep. 2010 May; 11(3):139-46. PMID: 20425619.

Citations:
Gomella LG. Re: Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer. Eur Urol. 2010 May; 57(5):915-6. PMID: 20945545.

Citations:
Metalli D, Lovat F, Tripodi F, Genua M, Xu SQ, Spinelli M, Alberghina L, Vanoni M, Baffa R, Gomella LG, Iozzo RV, Morrione A. The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin. Am J Pathol. 2010 Jun; 176(6):2997-3006. PMID: 20395438.

Citations:
Gomella LG. Prostate cancer screening "reloaded". Can J Urol. 2010 Apr; 17(2):5057. PMID: 20398441.

Citations:
Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, Rittmaster RS. Effect of dutasteride on the risk of prostate cancer. N Engl J Med. 2010 Apr 1; 362(13):1192-202. PMID: 20357281.

Citations:
Gomella LG. Doctor google and the internet prescription. Can J Urol. 2010 Feb; 17(1):4971. PMID: 20156374.

Citations:
Gomella LG, Lallas CD, Perkel R, Folia C, Hirsch I, Das A, Shenot P. Uropharmacology in primary care: 2010 update. Can J Urol. 2010 Feb; 17 Suppl 1:35-51. PMID: 20170599.

Citations:
Trabulsi EJ, Zola JC, Gomella LG, Lallas CD. Transition from pure laparoscopic to robotic-assisted radical prostatectomy: a single surgeon institutional evolution. Urol Oncol. 2010 Jan-Feb; 28(1):81-5. PMID: 20123354.

Citations:
Sartor O, Gomella LG, Gagnier P, Melich K, Dann R. Dutasteride and bicalutamide in patients with hormone-refractory prostate cancer: the Therapy Assessed by Rising PSA (TARP) study rationale and design. Can J Urol. 2009 Oct; 16(5):4806-12. PMID: 19796455.

Citations:
Gomella LG. Health policy: Do end-of-life discussions have a role in health care reform? Nat Rev Urol. 2009 Oct; 6(10):524-5. PMID: 19806168.

Citations:
Baffa R, Fassan M, Volinia S, O'Hara B, Liu CG, Palazzo JP, Gardiman M, Rugge M, Gomella LG, Croce CM, Rosenberg A. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol. 2009 Oct; 219(2):214-21. PMID: 19593777.

Citations:
Comstock CE, Augello MA, Benito RP, Karch J, Tran TH, Utama FE, Tindall EA, Wang Y, Burd CJ, Groh EM, Hoang HN, Giles GG, Severi G, Hayes VM, Henderson BE, Le Marchand L, Kolonel LN, Haiman CA, Baffa R, Gomella LG, Knudsen ES, Rui H, Henshall SM, Sutherland RL, Knudsen KE. Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer. Clin Cancer Res. 2009 Sep 1; 15(17):5338-49. PMID: 19706803.

Citations:
Gomella LG, Johannes J, Trabulsi EJ. Current prostate cancer treatments: effect on quality of life. Urology. 2009 May; 73(5 Suppl):S28-35. PMID: 19375624.

Citations:
Pe ML, Trabulsi EJ, Kedika R, Pequignot E, Dicker AP, Gomella LG, Valicenti RK. Effect of percentage of positive prostate biopsy cores on biochemical outcome in low-risk PCa treated with brachytherapy or 3D-CRT. Urology. 2009 Jun; 73(6):1328-34. PMID: 19376564.

Citations:
D'Arca D, LeNoir J, Wildemore B, Gottardo F, Bragantini E, Shupp-Byrne D, Zanesi N, Fassan M, Croce CM, Gomella LG, Baffa R. Prevention of urinary bladder cancer in the FHIT knock-out mouse with Rofecoxib, a Cox-2 inhibitor. Urol Oncol. 2010 Mar-Apr; 28(2):189-94. PMID: 19372053.

Citations:
Lallas CD, Pe ML, Patel JV, Sharma P, Gomella LG, Trabulsi EJ. Transperitoneal robotic-assisted laparoscopic prostatectomy after prosthetic mesh herniorrhaphy. JSLS. 2009 Apr-Jun; 13(2):142-7. PMID: 19660206.

Citations:
Gomella LG. Editorial comment on: A new generation of optical diagnostics for bladder cancer: technology, diagnostic accuracy, and future applications. Eur Urol. 2009 Aug; 56(2):296-7. PMID: 19285789.

Citations:
Lovat F, Bitto A, Xu SQ, Fassan M, Goldoni S, Metalli D, Wubah V, McCue P, Serrero G, Gomella LG, Baffa R, Iozzo RV, Morrione A. Proepithelin is an autocrine growth factor for bladder cancer. Carcinogenesis. 2009 May; 30(5):861-8. PMID: 19237611.

Citations:
Gomella LG. From the Lichtleiter to capsule cystoscopy. Eur Urol. 2009 May; 55(5):1034-6. PMID: 19246152.

Citations:
Linden RA, Weiner PR, Gomella LG, Dicker AP, Suh DB, Trabulsi EJ, Valicenti RK. Technique of outpatient placement of intraprostatic fiducial markers before external beam radiotherapy. Urology. 2009 Apr; 73(4):881-6. PMID: 19193411.

Citations:
Gomella LG. The impact of the impact factor. Can J Urol. 2009 Feb; 16(1):4445-6. PMID: 19222878.

Citations:
Monami G, Emiliozzi V, Bitto A, Lovat F, Xu SQ, Goldoni S, Fassan M, Serrero G, Gomella LG, Baffa R, Iozzo RV, Morrione A. Proepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growth. Am J Pathol. 2009 Mar; 174(3):1037-47. PMID: 19179604.

Citations:
Gomella LG. Effective testosterone suppression for prostate cancer: is there a best castration therapy? Rev Urol. 2009; 11(2):52-60. PMID: 19680526.

Citations:
Gomella LG. Percutaneous nephrostolithotomy--is it time to abandon extracorporeal shock wave lithotripsy? J Urol. 2009 Jan; 181(1):11-2. PMID: 19012903.

Citations:
Patel JV, Chambers CV, Gomella LG. Hematuria: etiology and evaluation for the primary care physician. Can J Urol. 2008 Aug; 15 Suppl 1:54-61; discussion 62. PMID: 18700066.

Citations:
Gittens PR, Lallas CD, Pe ML, Perkel R, Folia C, Gomella LG. Uropharmacology for the primary care physician. Can J Urol. 2008 Aug; 15 Suppl 1:78-91; discussion 91. PMID: 18700069.

Citations:
Trabulsi EJ, Linden RA, Gomella LG, McGinnis DE, Strup SE, Lallas CD. The addition of robotic surgery to an established laparoscopic radical prostatectomy program: effect on positive surgical margins. Can J Urol. 2008 Apr; 15(2):3994-9. PMID: 18405448.

Citations:
Gomella LG. Re: identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911. Eur Urol. 2008 Apr; 53(4):855-6. PMID: 18441534.

Citations:
Brown JA, Chenven E, Looney SW, Miller KM, Strup SE, Bagley DH, Gomella LG. Hand-assisted laparoscopic nephroureterectomy (HALNU): an assessment of the impact of obesity in 50 procedures. J Laparoendosc Adv Surg Tech A. 2008 Feb; 18(1):61-8. PMID: 18266577.

Citations:
Baffa R, Fassan M, Sevignani C, Vecchione A, Ishii H, Giarnieri E, Iozzo RV, Gomella LG, Croce CM. Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis. Carcinogenesis. 2008 Apr; 29(4):846-8. PMID: 18192690.

Citations:
Nelson ED, Slotoroff CB, Gomella LG, Halpern EJ. Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score. Urology. 2007 Dec; 70(6):1136-40. PMID: 18158034.

Citations:
Fassan M, Trabulsi EJ, Gomella LG, Baffa R. Targeted therapies in the management of metastatic bladder cancer. Biologics. 2007 Dec; 1(4):393-406. PMID: 19707309.

Citations:
Linden RA, Trabulsi EJ, Forsberg F, Gittens PR, Gomella LG, Halpern EJ. Contrast enhanced ultrasound flash replenishment method for directed prostate biopsies. J Urol. 2007 Dec; 178(6):2354-8. PMID: 17936814.

Citations:
Glassman DT, Merriam WG, Trabulsi EJ, Byrne D, Gomella L. Rhabdomyolysis after laparoscopic nephrectomy. JSLS. 2007 Oct-Dec; 11(4):432-7. PMID: 18237506.

Citations:
Chodak G, Gomella L, Phung de H. Combined androgen blockade in advanced prostate cancer: looking back to move forward. Clin Genitourin Cancer. 2007 Sep; 5(6):371-8. PMID: 17956709.

Citations:
Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F, Gomella LG, Croce CM, Baffa R. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol. 2007 Sep-Oct; 25(5):387-92. PMID: 17826655.

Citations:
Glassman D, Chawla SN, Waldman I, Johannes J, Byrne DS, Trabulsi EJ, Gomella LG. Correlation of pathology with tumor size of renal masses. Can J Urol. 2007 Aug; 14(4):3616-20. PMID: 17784981.

Citations:
Duchene DA, Winfield HN, Cadeddu JA, Clayman RV, Gomella LG, Kavoussi LR, Mikhail AA, Park S, Permpongkosol S, Shalhav AL. Multi-institutional survey of laparoscopic ureterolysis for retroperitoneal fibrosis. Urology. 2007 Jun; 69(6):1017-21. PMID: 17572177.

Citations:
Fleshner N, Gomella LG, Cookson MS, Finelli A, Evans A, Taneja SS, Lucia MS, Wolford E, Somerville MC, Rittmaster R. Delay in the progression of low-risk prostate cancer: rationale and design of the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trial. Contemp Clin Trials. 2007 Nov; 28(6):763-9. PMID: 17573244.

Citations:
Grossman HB, Gomella L, Fradet Y, Morales A, Presti J, Ritenour C, Nseyo U, Droller MJ. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. J Urol. 2007 Jul; 178(1):62-7. PMID: 17499283.

Citations:
Fradet Y, Grossman HB, Gomella L, Lerner S, Cookson M, Albala D, Droller MJ. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. J Urol. 2007 Jul; 178(1):68-73; discussion 73. PMID: 17499291.

Citations:
Abraham R, Pagano F, Gomella LG, Baffa R. Chromosomal deletions in bladder cancer: shutting down pathways. Front Biosci. 2007; 12:826-38. PMID: 17127340.

Citations:
Gomella LG. Global update on the use of hormonal therapy for the management of high-risk prostate cancer: introduction. BJU Int. 2007 Jan; 99 Suppl 1:1. PMID: 17229158.

Citations:
Gomella LG. Contemporary use of hormonal therapy in prostate cancer: managing complications and addressing quality-of-life issues. BJU Int. 2007 Jan; 99 Suppl 1:25-9; discussion 30. PMID: 17229166.

Citations:
Lawton CA, DeSilvio M, Lee WR, Gomella L, Grignon D, Gillin M, Morton G, Pisansky T, Sandler H. Results of a phase II trial of transrectal ultrasound-guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (radiation therapy oncology group 98-05). Int J Radiat Oncol Biol Phys. 2007 Jan 1; 67(1):39-47. PMID: 17084551.

Citations:
Monami G, Gonzalez EM, Hellman M, Gomella LG, Baffa R, Iozzo RV, Morrione A. Proepithelin promotes migration and invasion of 5637 bladder cancer cells through the activation of ERK1/2 and the formation of a paxillin/FAK/ERK complex. Cancer Res. 2006 Jul 15; 66(14):7103-10. PMID: 16849556.

Citations:
Brown JA, Garlitz CJ, Hubosky SG, Gomella LG. Hand-assisted laparoscopic ureterolysis to treat ureteral obstruction secondary to idiopathic retroperitoneal fibrosis: assessment of a novel technique and initial series. Urology. 2006 Jul; 68(1):46-9. PMID: 16806417.

Citations:
Gomella LG. Targeting the genetic basis of transitional cell carcinoma. J Urol. 2006 Jun; 175(6):1986. PMID: 16697780.

Citations:
Trabulsi EJ, Merriam WG, Gomella LG. New imaging techniques in prostate cancer. Curr Urol Rep. 2006 May; 7(3):175-80. PMID: 16630520.

Citations:
Kalra P, Glassman DT, Gomella LG, Strup SE, McGinnis DE, Simon DR, Chang MF, Byrne DS, Kuo RL. Outcomes of hand-assisted laparoscopic nephrectomy in technically challenging cases. Urology. 2006 Jan; 67(1):45-9. PMID: 16413330.

Citations:
Halpern EJ, Ramey JR, Strup SE, Frauscher F, McCue P, Gomella LG. Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging. Cancer. 2005 Dec 1; 104(11):2373-83. PMID: 16240450.

Citations:
Brown JA, Strup SE, Chenven E, Bagley D, Gomella LG. Hand-assisted laparoscopic nephroureterectomy: analysis of distal ureterectomy technique, margin status, and surgical outcomes. Urology. 2005 Dec; 66(6):1192-6. PMID: 16360439.

Citations:
Ives EP, Gomella LG, Halpern EJ. Effect of dutasteride therapy on Doppler US evaluation of prostate: preliminary results. Radiology. 2005 Oct; 237(1):197-201. PMID: 16183933.

Citations:
Ives EP, Burke MA, Edmonds PR, Gomella LG, Halpern EJ. Quantitative computed tomography perfusion of prostate cancer: correlation with whole-mount pathology. Clin Prostate Cancer. 2005 Sep; 4(2):109-12. PMID: 16197611.

Citations:
Strup S, Garrett J, Gomella L, Rowland R. Laparoscopic partial nephrectomy: hand-assisted technique. J Endourol. 2005 May; 19(4):456-9; discussion 459-60. PMID: 15910255.

Citations:
Moreno JG, Miller MC, Gross S, Allard WJ, Gomella LG, Terstappen LW. Circulating tumor cells predict survival in patients with metastatic prostate cancer. Urology. 2005 Apr; 65(4):713-8. PMID: 15833514.

Citations:
Trabulsi EJ, Kalra P, Gomella LG. New approaches to the minimally invasive treatment of kidney tumors. Cancer J. 2005 Jan-Feb; 11(1):57-63. PMID: 15831225.

Citations:
Gomella LG. Chemoprevention using dutasteride: the REDUCE trial. Curr Opin Urol. 2005 Jan; 15(1):29-32. PMID: 15586026.

Citations:
Gomella LG. Addressing the needs of the high-risk prostate cancer patient. Rev Urol. 2005; 7 Suppl 5:S18-28. PMID: 16985880.

Citations:
Brown JA, Garlitz C, Strup SE, Hubosky SG, Gomella L. Laparoscopic radical prostatectomy after neoadjuvant hormonal therapy: an apparently safe and effective procedure. J Laparoendosc Adv Surg Tech A. 2004 Dec; 14(6):335-8. PMID: 15684777.

Citations:
Vecchione A, Sevignani C, Giarnieri E, Zanesi N, Ishii H, Cesari R, Fong LY, Gomella LG, Croce CM, Baffa R. Inactivation of the FHIT gene favors bladder cancer development. Clin Cancer Res. 2004 Nov 15; 10(22):7607-12. PMID: 15569992.

Citations:
Andriole G, Bostwick D, Brawley O, Gomella L, Marberger M, Tindall D, Breed S, Somerville M, Rittmaster R. Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial. J Urol. 2004 Oct; 172(4 Pt 1):1314-7. PMID: 15371831.

Citations:
Vecchione A, Galetti TP, Gardiman M, Ishii H, Giarnieri E, Pagano F, Gomella LG, Croce CM, Baffa R. Collecting duct carcinoma of the kidney: an immunohistochemical study of 11 cases. BMC Urol. 2004 Sep 9; 4:11. PMID: 15357873.

Citations:
Lee HM, Solan MJ, Lupinacci P, Gomella LG, Valicenti RK. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy. Urology. 2004 Jul; 64(1):84-9. PMID: 15245941.

Citations:
Gomella LG. When prostate cancer markers become unreliable: the PCPT dilemma. Urol Oncol. 2004 May-Jun; 22(3):260-1. PMID: 15495370.

Citations:
Brown JA, Hubosky SG, Gomella LG, Strup SE. Hand assisted laparoscopic partial nephrectomy for peripheral and central lesions: a review of 30 consecutive cases. J Urol. 2004 Apr; 171(4):1443-6. PMID: 15017194.

Citations:
Valicenti RK, Chervoneva I, Gomella LG. Importance of margin extent as a predictor of outcome after adjuvant radiotherapy for Gleason score 7 pT3N0 prostate cancer. Int J Radiat Oncol Biol Phys. 2004 Mar 15; 58(4):1093-7. PMID: 15001249.

Citations:
Brown JA, Garlitz C, Gomella LG, McGinnis DE, Diamond SM, Strup SE. Perioperative morbidity of laparoscopic radical prostatectomy compared with open radical retropubic prostatectomy. Urol Oncol. 2004 Mar-Apr; 22(2):102-6. PMID: 15082005.

Citations:
O'Hara SM, Moreno JG, Zweitzig DR, Gross S, Gomella LG, Terstappen LW. Multigene reverse transcription-PCR profiling of circulating tumor cells in hormone-refractory prostate cancer. Clin Chem. 2004 May; 50(5):826-35. PMID: 14988224.

Citations:
Gomella LG, Zeltser I, Valicenti RK. Use of neoadjuvant and adjuvant therapy to prevent or delay recurrence of prostate cancer in patients undergoing surgical treatment for prostate cancer. Urology. 2003 Dec 29; 62 Suppl 1:46-54. PMID: 14747041.

Citations:
Brown JA, Garlitz C, Gomella LG, Hubosky SG, Diamond SM, McGinnis D, Strup SE. Pathologic comparison of laparoscopic versus open radical retropubic prostatectomy specimens. Urology. 2003 Sep; 62(3):481-6. PMID: 12946751.

Citations:
Gomella LG. Laparoscopy and urologic oncology--I now pronounce you man and wife. J Urol. 2003 Jun; 169(6):2057-8. PMID: 12771718.

Citations:
Valicenti RK, Gomella LG, Perez CA. Radiation therapy after radical prostatectomy: a review of the issues and options. Semin Radiat Oncol. 2003 Apr; 13(2):130-40. PMID: 12728442.

Citations:
Halpern EJ, Gomella LG. Pseudomass of the bladder neck after prostatectomy: report of two cases. Radiology. 2003 Mar; 226(3):833-5. PMID: 12601184.

Citations:
Wilkinson S, Gomella LG, Smith JA, Brawer MK, Dawson NA, Wajsman Z, Dai L, Chodak GW. Attitudes and use of complementary medicine in men with prostate cancer. J Urol. 2002 Dec; 168(6):2505-9. PMID: 12441950.

Citations:
Halpern EJ, Frauscher F, Strup SE, Nazarian LN, O'Kane P, Gomella LG. Prostate: high-frequency Doppler US imaging for cancer detection. Radiology. 2002 Oct; 225(1):71-7. PMID: 12354987.

Citations:
Halpern EJ, Frauscher F, Rosenberg M, Gomella LG. Directed biopsy during contrast-enhanced sonography of the prostate. AJR Am J Roentgenol. 2002 Apr; 178(4):915-9. PMID: 11906872.

Citations:
Vecchione A, Ishii H, Baldassarre G, Bassi P, Trapasso F, Alder H, Pagano F, Gomella LG, Croce CM, Baffa R. FEZ1/LZTS1 is down-regulated in high-grade bladder cancer, and its restoration suppresses tumorigenicity in transitional cell carcinoma cells. Am J Pathol. 2002 Apr; 160(4):1345-52. PMID: 11943719.

Citations:
Halpern EJ, Frauscher F, Forsberg F, Strup SE, Nazarian LN, O'Kane P, Gomella LG. High-frequency Doppler US of the prostate: effect of patient position. Radiology. 2002 Mar; 222(3):634-9. PMID: 11867778.

Citations:
Lee D, Trabulsi E, McGinnis D, Strup S, Gomella LG, Bagley D. Totally endoscopic management of upper tract transitional-cell carcinoma. J Endourol. 2002 Feb; 16(1):37-41. PMID: 11890449.

Citations:
Halpern EJ, McCue PA, Aksnes AK, Hagen EK, Frauscher F, Gomella LG. Contrast-enhanced US of the prostate with Sonazoid: comparison with whole-mount prostatectomy specimens in 12 patients. Radiology. 2002 Feb; 222(2):361-6. PMID: 11818600.

Citations:
Sandler H, Shipley WU, Gomella L, Pienta K, Bard RH, Bruner D, Clark R, DeSilvio M, Gaspar L, Gillin M, Grignon D, Hammond E, Hanks G, Heydon KH, Kaufman DS, Lee WR, Michalski J, Mydlo J, Pisansky T, Pollack A, Porterfield H, Rifkin M, Roach M, Sanda M, True L, Vijayakumar S, Winter KA, Zeitman A. Radiation Therapy Oncology Group. Research Plan 2002-2006. Genitourinary Cancer Committee. Int J Radiat Oncol Biol Phys. 2001; 51(3 Suppl 2):28-38. PMID: 11641012.

Citations:
Ginsburg R, Bullard D, Eisenberg B, Gomella L, Johnstone D, Pisters PW, Sigurdson E, Weber R, Levenback C. Radiation Therapy Oncology Group. Research Plan 2002-2006. Surgical Oncology Committee. Int J Radiat Oncol Biol Phys. 2001; 51(3 Suppl 2):92-5. PMID: 11641022.

Citations:
Mastrangelo MJ, Eisenlohr LC, Gomella L, Lattime EC. Poxvirus vectors: orphaned and underappreciated. J Clin Invest. 2000 Apr; 105(8):1031-4. PMID: 10772644.

Citations:
Corn BW, Valicenti RK, Mulholland SG, Hyslop T, Gomella L. Stage T3 prostate cancer: a nonrandomized comparison between definitive irradiation and induction hormonal manipulation plus prostatectomy. Urology. 1998 May; 51(5):782-7. PMID: 9610592.

Citations:
Hudes GR, Nathan F, Khater C, Haas N, Cornfield M, Giantonio B, Greenberg R, Gomella L, Litwin S, Ross E, Roethke S, McAleer C. Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer. J Clin Oncol. 1997 Sep; 15(9):3156-63. PMID: 9294479.

Citations:
Werner-Wasik M, Whittington R, Malkowicz SB, Corn BW, Arger P, Reisinger S, Langlotz C, Alexander A, D'Amico AV, Hyslop T, Gomella L, Brownstein K, Wein AJ. Prostate imaging may not be necessary in nonpalpable carcinoma of the prostate. Urology. 1997 Sep; 50(3):385-9. PMID: 9301702.

Citations:
Rosen EM, Joseph A, Jin L, Yao Y, Chau MH, Fuchs A, Gomella L, Hastings H, Goldberg ID, Weiss GH. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder. J Urol. 1997 Jan; 157(1):72-8. PMID: 8976219.

Citations:
Watanabe T, Rivas DA, Miettinen M, Gomella L, Chancellor MB. Total incontinence secondary to sphincter destruction after prostate cryotherapy for recurrent prostatic carcinoma. Int J Urol. 1996 Jul; 3(4):324-5. PMID: 8844295.

Citations:
Hudes GR, Nathan FE, Khater C, Greenberg R, Gomella L, Stern C, McAleer C. Paclitaxel plus estramustine in metastatic hormone-refractory prostate cancer. Semin Oncol. 1995 Oct; 22(5 Suppl 12):41-5. PMID: 7481860.

Citations:
Bishoff JT, Reyes A, Thompson IM, Harris MJ, St Clair SR, Gomella L, Butzin CA. Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection. Urology. 1995 Feb; 45(2):270-4. PMID: 7531901.

Citations:
Spencer JA, Alexander AA, Gomella L, Matteucci T, Goldberg BB. Ultrasound-guided four quadrant biopsy of the prostate: efficacy in the diagnosis of isoechoic cancer. Clin Radiol. 1994 Oct; 49(10):711-4. PMID: 7955836.

Citations:
Spencer JA, Alexander AA, Gomella L, Matteucci T, Goldberg BB. Clinical and US findings in prostate cancer: patients with normal prostate-specific antigen levels. Radiology. 1993 Nov; 189(2):389-93. PMID: 7692464.

Citations:
Pietrzkowski Z, Mulholland G, Gomella L, Jameson BA, Wernicke D, Baserga R. Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1. Cancer Res. 1993 Mar 1; 53(5):1102-6. PMID: 8439954.

Citations:
Haas GP, Pittaluga S, Gomella L, Travis WD, Sherins RJ, Doppman JL, Linehan WM, Robertson C. Clinically occult Leydig cell tumor presenting with gynecomastia. J Urol. 1989 Nov; 142(5):1325-7. PMID: 2810523.

Citations:

Year	Publications
1995	2
1996	1
1997	3
1998	1
2000	1
2001	2
2002	7
2003	5
2004	10
2005	9
2006	6
2007	14
2008	7
2009	15
2010	18
2011	21
2012	15
2013	15
2014	17
2015	21
2016	14
2017	16
2018	13
2019	17
2020	19
2021	18
2022	14
2023	9
2024	16

GOMELLA's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (484)

Explore

Co-Authors (121)

Explore

Similar People (60)

Explore

Same Department

Explore

Physical Neighbors

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement